-
The UNAIDS annual report warns that Trump era HIV funding cuts could lead to 6 million more infections and 4 million deaths by 2029 — as low-income countries struggle to fill the gap.
-
Journavx is the first truly new painkiller approved by the Food and Drug Administration in more than 20 years. But the drug is expensive, and many people can't get it yet.
-
The Trump Administration's financial cuts to global development programs pose a challenge for organizations fighting deadly infectious diseases both in the U.S. and abroad.
-
According to the American Psychiatric Association, more than 30% of Americans say their sleep quality is poor or they aren’t getting enough sleep each night.
-
A recent study shows that top scavengers, like hyenas, can be beneficial for human health. But the same study reveals that scavenger populations are declining and could mean more disease for humans.
-
The first new non-opioid for severe acute pain has been on the market for a few months. But it's a lot more expensive than opioids, and many people can't get it because of spotty insurance coverage.
-
During the COVID-19 pandemic, skepticism of science and medicine broke down along partisan lines.
-
Rural hospitals that are dependent on Medicaid funding can tap into a $50 billion fund in President Trump's new tax cut and spending law, which cut Medicaid spending overall.
-
The U.S. has hit an unwelcome milestone in measles cases this year. The CDC is reporting 1,288 cases across the country. The disease was declared eliminated 25 years ago.
-
A recent study shows that top scavengers, like hyenas, can be beneficial for human health. But the same study reveals that scavenger populations are declining and could mean more disease for humans.
-
The symptoms can include nerve pain, emotional numbness and sexual dysfunction and can last for years after stopping the drugs. Patients are pushing for recognition and more research.
-
On Tuesday, scientists held an event organized by House Democrats in which they stood in front of posters outlining their work — and the federal cuts that now threaten it.